Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • XLK vs GSK✓SelectedUSD · GSKXLK vs GSK performance historyLatest closeAs of+0.34%11/18
Stock and ETF performance explorer

XLK vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+99.9%
GSK return
+42.7%
Excess return
+57.2%
Maximum drawdown
-33.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D+0.3%-1.3%+1.7%+0.5%
7D-6.1%-3.1%-2.9%-5.8%
30D-11.9%-0.9%-11.0%-11.9%
3M-11.6%-4.2%-7.5%-11.3%
6M-5.8%-1.6%-4.2%-6.0%
YTD+14.2%+2.6%+11.6%+12.9%
1Y+18.0%+6.2%+11.8%+16.0%
3Y+82.6%+55.0%+27.7%+64.0%
5Y+99.9%+42.8%+57.1%+65.9%
All+99.9%+42.7%+57.2%+65.9%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling